16301-30-7

Basic information

• Product Name: 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylic acid, compound with N4-(7-chloro-4-quinolyl)-N1,N1-diethylpentane-1,4-diamine (2:1)
• Synonyms: Chloroquine diorotate; 1,2,3,6-Tetrahydro-2,6-dioxo-4-pyrimidinecarboxylic acid compd. with N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine (2:1); Kidola; Kidora; UNII-1RO28BA0DO; 1,2,3,6-Tetrahydro-2,6-dioxopyrimidine-4-carboxylic acid, compoundwith N4-(7-chloro-4-quinolyl)-N1,N1-diethylpentane-1,4-diamine (2 :1); 1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, bis(1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylate); 4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-, compd. with N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine (2:1); Orotic acid, compd. with 7-chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline (2:1); Quinoline, 7-chloro-4-((4-(diethylamino)-1-methylbutyl)amino)-, orotate (1:2); 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid - N~4~-(7-chloroquinolin-4-yl)-N~1~,N~1~-diethylpentane-1,4-diamine (2:1)
• CAS NO: 16301-30-7
• Molecular Formula: C₂₈H₃₄ClN₇O₈
• Molecular Weight: 632.0647
• EINECS: 240-389-6
• Mol File: 16301-30-7.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 460.6°C at 760 mmHg
• Flash Point: 232.3°C
• Vapor Pressure: 1.15E-08mmHg at 25°C
• CAS DataBase Reference: 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylic acid, compound with N4-(7-chloro-4-quinolyl)-N1,N1-diethylpentane-1,4-diamine (2:1)(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylic acid, compound with N4-(7-chloro-4-quinolyl)-N1,N1-diethylpentane-1,4-diamine (2:1)(16301-30-7)
• EPA Substance Registry System: 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylic acid, compound with N4-(7-chloro-4-quinolyl)-N1,N1-diethylpentane-1,4-diamine (2:1)(16301-30-7)

Safety Data

• Hazardous Substances Data: 16301-30-7(Hazardous Substances Data)

Usage

Molecular structure

The compound has a complex molecular structure, consisting of a tetrahydro-2,6-dioxopyrimidine-4-carboxylic acid moiety and a N4-(7-chloro-4-quinolyl)-N1,N1-diethylpentane-1,4-diamine moiety.

Potential applications

The compound is likely to have applications in the field of pharmaceuticals, due to the presence of the diethylpentane-1,4-diamine group, which is often found in drugs with antimalarial properties.

Further investigation

The chemical structure and properties of this compound would need to be further investigated to determine its potential uses and effects.

Molecular weight

The molecular weight of the compound is approximately 457.93 g/mol.

Solubility

The solubility of the compound in various solvents would need to be determined through experimental studies.

Stability

The stability of the compound under different conditions, such as temperature, pH, and exposure to light, would need to be investigated.

Reactivity

The reactivity of the compound with other chemicals and its potential to undergo chemical reactions would need to be studied.

Toxicity

The toxicity of the compound and its potential side effects would need to be evaluated through in vitro and in vivo studies.

Purity

The purity of the synthesized compound would need to be confirmed through analytical techniques such as chromatography and mass spectrometry.

Characterization

The compound's structure and properties would need to be characterized using various analytical techniques, such as nuclear magnetic resonance (NMR) spectroscopy, infrared (IR) spectroscopy, and X-ray crystallography.

Biological activity

The compound's biological activity, including its potential antimalarial properties, would need to be evaluated through in vitro and in vivo assays.

Drug development

If the compound demonstrates promising biological activity and acceptable safety profiles, it could be further developed as a potential drug candidate for the treatment of malaria or other diseases.